ZRB2538

Anti-TRIM14 Antibody, clone 1J17 ZooMAb^® Rabbit Monoclonal

recombinant, expressed in HEK 293 cells

• 同義詞: Tripartite motif-containing protein 14
• 分類程式碼代碼: 12352203

屬性

• 生物源: rabbit
• 品質等級: 200
• 重組細胞: expressed in HEK 293 cells
• 共軛: unconjugated
• 抗體表格: purified antibody
• 抗體產品種類: primary antibodies
• 無性繁殖: 1J17, recombinant monoclonal
• 描述: recombinant, expressed in HEK 293 cells
• 產品線: ZooMAb^® learn more
• 形狀: lyophilized
• 分子量: calculated mol wt 49.77 kDa; observed mol wt ~50 kDa
• 純化經由: using Protein A
• 物種活性: human
• 包裝: antibody small pack of 25
• 加強驗證: recombinant expression; Learn more about Antibody Enhanced Validation
• 技術: affinity binding assay: suitable; immunocytochemistry: suitable; immunohistochemistry: suitable; western blot: suitable
• 同型: IgG
• 表位序列: N-terminal half
• Protein ID登錄號: NP_055603
• UniProt登錄號: Q14142
• 運輸包裝: ambient
• 儲存溫度: 2-8°C
• 基因資訊: human ... TRIM14(9830)

描述

一般說明

ZooMAb^® antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb^® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb^® antibodies are reliably available and ready to ship when you need them.

特異性

Clone 1J17 is a ZooMAb^® recombinant rabbit monoclonal antibody that specifically detects TRIM14. It targets an epitope within 21 amino acids from the N-terminal half.

免疫原

KLH-conjugated linear peptide corresponding to 21 amino acids from the N-terminal half of human TRIM14.

應用

Quality Control Testing



Evaluated by Western Blotting in HeLa cell lysate.



Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected TRIM14 in HeLa cell lysate.

Tested Applications

Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected TRIM14 in human liver tissue sections.

Affinity Binding Assay: A representative lot of this antibody bound TRIM14 peptide with at least one thousand-fold (1,000X) higher than with non-specific control peptide.

Immunocytochemistry Analysis: A 1:1,000 dilution from a representative lot detected TRIM14 in HeLa cells.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

標靶描述

Tripartite motif-containing protein 14 (UniProt: Q14142) is encoded by the TRIM14 (also known as KIAA0129) gene (Gene ID: 9830) in human. The protein encoded by TRIM14 is a member of the tripartite motif (TRIM) family. It plays an essential role in the innate immune defense against viruses and bacteria. TRIM14 includes zinc-binding domain (B-box type) and two coiled-coil regions. The B-box zinc finger is responsible for inhibition of SPI1-mediated transcriptional activation. It lacks the N-terminal RING domain, which is found in most other proteins in the TRIM family. TRIM14 expressed in various tissues with highest expression in liver and also in immune-related tissues such as the spleen, thymus, and peripheral blood leukocytes and is undetectable in skeletal muscle. The protein localizes to cytoplasmic bodies; mitochondria and cytoplasmic vesicle (phagosomes). Four alternatively spliced transcript variants for this gene have been described. It is involved in various cellular processes and key functions include Antiviral defense, Autophagy, Inflammatory Response and Cell Proliferation and Survival. TRIM14 is crucial in the host defense against viral infections. Its antiviral activity is significant in the context of infections by viruses such as HIV, influenza, and hepatitis B and C. The antiviral mechanism is by IFN-stimulated genes and Cytokine Signaling in Immune system. TRIM14 is also known to be associated with Spondyloepimetaphyseal Dysplasia of Geneviève Type. TRIM14 may contribute to the pathogenesis of autoimmune diseases if its regulatory mechanisms are disrupted. This ZooMAb^® recombinant monoclonal antibody, generated by our proprietary technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.

外觀

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.

重構

300 µg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

儲存和穩定性

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

法律資訊

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable